Apimeds Pharmaceuticals US

APUS · NYSE American

$3.41−$0.09 (−2.57%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $3.50

Latest news

Press releaseOct 13, 9:43 AM ETGlobe Newswire
NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide
Press releaseOct 9, 6:00 PM ETGlobe Newswire
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure
NewsOct 5, 10:08 AM ETAkanksha Bakshi
Why Is Apimeds Pharmaceuticals Stock Gaining Monday?
Press releaseOct 5, 8:00 AM ETGlobe Newswire
MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network
Press releaseSep 29, 8:30 AM ETGlobe Newswire
MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media
NewsSep 28, 8:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsSep 24, 9:17 PM ETShivdeep Dhaliwal
Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Investors' Radars Today
NewsSep 24, 12:02 PM ETAvi Kapoor
Crude Oil Rises Over 4%; Darden Earnings Miss Views
NewsSep 24, 11:15 AM ETHenry Khederian
Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?
NewsSep 24, 9:43 AM ETAvi Kapoor
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
Press releaseSep 24, 8:30 AM ETGlobe Newswire
MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits
Press releaseSep 18, 2:00 PM ETGlobe Newswire
IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.
NewsAug 27, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsAug 21, 8:06 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsAug 18, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsAug 18, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsAug 17, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsAug 17, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseAug 3, 9:00 AM ETGlobe Newswire
NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange
Press releaseJul 28, 8:30 AM ETGlobe Newswire
MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October
NewsMay 11, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsMay 7, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMay 6, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMay 6, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseMay 5, 2:07 PM ETBusiness Wire
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
Press releaseApr 16, 10:14 AM ETBusiness Wire
Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
Press releaseApr 15, 6:35 PM ETBusiness Wire
Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
Press releaseMar 24, 8:30 AM ETBusiness Wire
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
NewsMar 17, 5:12 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsFeb 19, 12:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsFeb 11, 4:53 PM ET
Apimeds Pharmaceuticals And Lōkahi Therapeutics Secure FDA Type C Meeting To Discuss LT-100, Non-Opioid Biologic Candidate Being Developed For Osteoarthritis Treatment
Press releaseFeb 11, 4:51 PM ETBusiness Wire
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
Press releaseDec 10, 9:58 AM ETBusiness Wire
Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
Press releaseDec 1, 9:25 AM ETBusiness Wire
Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
NewsNov 18, 12:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseNov 10, 10:00 AM ETBusiness Wire
Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
Press releaseOct 14, 3:02 AM ETBusiness Wire
Apimeds Pharmaceuticals says "I love my Ducks" with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business
NewsSep 23, 5:07 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseSep 15, 6:24 PM ETBusiness Wire
Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
Press releaseSep 11, 9:54 PM ETBusiness Wire
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide

MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure

Why Is Apimeds Pharmaceuticals Stock Gaining Monday?

MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

12 Health Care Stocks Moving In Monday's Pre-Market Session

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Investors' Radars Today

Crude Oil Rises Over 4%; Darden Earnings Miss Views

Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?

Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000

MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS

Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

Apimeds Pharmaceuticals And Lōkahi Therapeutics Secure FDA Type C Meeting To Discuss LT-100, Non-Opioid Biologic Candidate Being Developed For Osteoarthritis Treatment

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

12 Health Care Stocks Moving In Tuesday's Intraday Session

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals says "I love my Ducks" with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

12 Health Care Stocks Moving In Tuesday's After-Market Session

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program